Exposome, Pollutants, Biology in the Older Subject: EXPOSAGE

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorCentre Hospitalier Universitaire de Nice

About this trial

Numerous factors, both individual and environmental, can influence aging, an individual's health, and their functional status. However, the understanding of the combined impact of lifestyle-related exposures (e.g., physical activity, diet, sleep) (personal external exposome), exposures to pollutants (environmental external exposome), and their biological responses (internal exposome)-in other words, the impact of the "exposome" on healthy aging-remains limited, particularly in characterizing the molecular mechanisms associated with these interactions. Exposome approaches identifying key exposures and molecular mechanisms could lead to a better understanding of how the environment, interacting with health behaviors, can affect functional status. Thus, the objective of this study is i) to evaluate the links between the external exposome, the internal exposome and the health of older and aging individuals, and ii) to identify biological markers associated with a vulnerable health status in older and aging individuals.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 55 or over

Affiliated with or beneficiaries of a social security scheme

Signed the informed consent form •-Persons residing in one of the following municipalities : Antibes, Le Bar-sur-Loup, Berre-les-Alpes, Beuil, Blausasc, Breil-sur-Roya, Cabris, Cannes, Carros, Clans, Contes, Drap, L'Escarène, Escragnolles, Fontan, La Gaude, Gilette, Grasse, Lantosque, Levens, Nice, Peillon, Peymeinade, Saint-André-de-la-Roche, Saint-Etienne-de-Tinée, Sospel, Tourrettes-sur-Loup, Vence, Tende

Disqualifiers

patients currently undergoing intensive drug treatment, including chemotherapy

Trial design

Design model

Single group

Treatments tested in this trial

  • Exposome assessment

    Other intervention

    Visit 1: blood sample, questionnaires on the personal exposome (lifestyle habits (e.g., physical activity, diet, stress) and social characteristics and health status) \| ii) Outpatient assessment: wearing a silicone bracelet for 7 days to measure external environmental exposure to pollutants and quantify physical activity \| iii) Visit 2: 1-year follow-up of health status

Treatment groups

400 Participants
are divided into 1 treatment group
Group A: Exposome assessmentOther 1 intervention

Trial outcomes

Primary outcomes

1

Frailty (health measure)

Frailty is assessed using the Groningen Frailty Indicator. The scale comprises 15 items. The total score ranges from 0 to 25, with a higher score being worse.

Time frame
at baseline and 12 months later

Secondary outcomes

1

Functional and health status

Disease presence : : Presence (yes/no) of chronic disease

Time frame
at baseline and 1 year
2

Physical functional capacities (health measure)

Physical functional capacities are assessed using the Short Physical Performance Battery which assess balance, walking capacities and strength via a sit to stand test

Time frame
at baseline and at 12 months
3

Quality of life (health measure)

Quality of life is assessed using the SF-12 questionnaire. The scale comprises 12 items.

Time frame
at baseline and 12 months
4

Autonomy (health measure)

Autonomy is assessed using the WHOQOL-OLD-AUT questionnaire. The scale comprises 4 items. The total score ranges from 4 to 20, with a higher score being better.

Time frame
at baseline and 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: